A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

NCT01918371 · clinicaltrials.gov ↗

COMPLETED

Status

323

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinal Vein Occlusion
Macular Edema

Interventions

DRUG: Anti-VEGF

Sponsor

Allergan